On April 30, 2026, Onconetix, Inc. held a special meeting where shareholders approved a reverse stock split proposal of 1-for-2 to 1-for-10, valid until April 2027, based on 3,464,686 shares outstanding. Additionally, they approved the adjournment to gather more votes if needed.